Kathleen D. Scott insider trades

Open-market stock purchases and sales by Kathleen D. Scott, Director at Dermata Therapeutics, Inc, from SEC Form 4 filings since Nov 18, 2019.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -31%.

Recent trades

DateStockTradeValue
Jun 16, 2026DRMA Dermata Therapeutics, IncSold$13
Jan 2, 2026SPRY ARS Pharmaceuticals, IncBought (not open market)—
Jan 2, 2026DRMA Dermata Therapeutics, IncBought (not open market)—

Companies traded

  • DRMA Dermata Therapeutics, Inc: 1 sale, last Jun 16, 2026
  • SPRY ARS Pharmaceuticals, Inc: 1 buy, 4 sales, last Jan 2, 2026
  • NKGN NKGen Biotech, Inc: other filings, last Dec 6, 2024
  • CNAT Conatus Pharmaceuticals Inc: other filings, last Nov 18, 2019

Get free alerts when Kathleen D. Scott files a new trade →